| Q37404016 | A case of an anaplastic meningioma metastasizing to the mediastinal lymph nodes |
| Q38135151 | A literature review of key molecular genetic aberrations in meningiomas: a potential role in the determination of radiosurgery outcomes |
| Q40867510 | A new patient-derived orthotopic malignant meningioma model treated with oncolytic herpes simplex virus. |
| Q38888517 | A novel component from citrus, ginger, and mushroom family exhibits antitumor activity on human meningioma cells through suppressing the Wnt/β-catenin signaling pathway |
| Q55422322 | A rare case of atypical/anaplastic meningioma with MDM2 amplification. |
| Q37581072 | A retrospective analysis of survival and prognostic factors after stereotactic radiosurgery for aggressive meningiomas |
| Q37202515 | A serum 6-miRNA panel as a novel non-invasive biomarker for meningioma |
| Q42445998 | AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistry |
| Q37427414 | Aberrant DNA methylation of alternative promoter of DLC1 isoform 1 in meningiomas |
| Q38201701 | Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review |
| Q47208014 | Advances in meningioma genetics: novel therapeutic opportunities |
| Q36493804 | Alterations of oxidative phosphorylation in meningiomas and peripheral nerve sheath tumors |
| Q42006939 | An elusive cause of pleural effusion |
| Q57306913 | An integrated genomic analysis of anaplastic meningioma identifies prognostic molecular signatures |
| Q34785965 | Application of CUSA Excel ultrasonic aspiration system in resection of skull base meningiomas |
| Q39538976 | Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival |
| Q39295367 | Atypical Meningioma: Referral Patterns, Treatment and Adherence to Guidelines. |
| Q49012546 | Atypical and ischemic features of embolized meningiomas. |
| Q34246609 | Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series |
| Q51166026 | Biological and demographic profile of meningiomas in a cohort of Egyptian patients: impact on tumor recurrence. |
| Q38728877 | Brain invasion in Meningiomas - Clinical considerations and impact of neuropathological evaluation: A systematic Review |
| Q26820849 | Brain tumors: Special characters for research and banking |
| Q36883373 | CCM3 Mutations Are Associated with Early-Onset Cerebral Hemorrhage and Multiple Meningiomas |
| Q92850702 | Can Systemic Inflammatory Markers Be Used to Predict the Pathological Grade of Meningioma Before Surgery? |
| Q53127390 | Clinical features and prognostic factors of WHO II and III adult spinal meningiomas: analysis of 25 cases in a single center. |
| Q53117505 | Clinical impact of targeted amplicon sequencing for meningioma as a practical clinical-sequencing system. |
| Q46250810 | Clinicopathologic features and pathogenesis of melanocytic colonization in atypical meningioma |
| Q36563246 | Clinicopathological analysis of metaplastic meningioma: report of 15 cases in Huashan Hospital |
| Q52940698 | Combined treatment by octreotide and everolimus: Octreotide enhances inhibitory effect of everolimus in aggressive meningiomas. |
| Q28943376 | Common variation at 10p12.31 near MLLT10 influences meningioma risk |
| Q34716061 | Curcumin acts anti-proliferative and pro-apoptotic in human meningiomas |
| Q38876931 | CyberKnife Stereotactic Radiosurgery for Atypical and Malignant Meningiomas. |
| Q34562612 | DNA methylation in the malignant transformation of meningiomas |
| Q35584376 | DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence |
| Q38910666 | Deficiency of the protein-tyrosine phosphatase DEP-1/PTPRJ promotes matrix metalloproteinase-9 expression in meningioma cells |
| Q35848234 | Development of patient-derived xenograft models from a spontaneously immortal low-grade meningioma cell line, KCI-MENG1. |
| Q35947699 | Differentially Expressed MicroRNAs in Meningiomas Grades I and II Suggest Shared Biomarkers with Malignant Tumors |
| Q90355703 | Diversity in tumor territory of meningioma: Protein expression in vascular endothelial growth factor and epidermal growth factor |
| Q36346636 | Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005. |
| Q35079099 | Dural-based metastatic carcinomas mimicking primary CNS neoplasia: report of 7 cases emphasizing the role of timely surgery and accurate pathologic evaluation |
| Q90704772 | Ear and Temporal Bone Pathology: Neural, Sclerosing and Myofibroblastic Lesions |
| Q41925124 | Epigenetics of Meningiomas |
| Q39298204 | Exploration of Involved Key Genes and Signaling Diversity in Brain Tumors |
| Q36375359 | Expression of somatostatin receptors (SSTR1-SSTR5) in meningiomas and its clinicopathological significance |
| Q50664835 | Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence. |
| Q48382150 | Genetic alterations associated with progression and recurrence in meningiomas. |
| Q47927353 | Genetic changes of MLH1 and MSH2 genes could explain constant findings on microsatellite instability in intracranial meningioma |
| Q38953562 | Genetic landscape of meningioma |
| Q35793582 | Genetic/molecular alterations of meningiomas and the signaling pathways targeted |
| Q56375615 | Genome-wide association analysis identifies a meningioma risk locus at 11p15.5 |
| Q50104280 | Genomic analysis of synchronous intracranial meningiomas with different histological grades |
| Q42548316 | Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations |
| Q64111257 | Grade III meningioma with gastro-intestinal tract and brain metastases: case report and review of the literature |
| Q97542718 | Histomolecular characterization of intracranial meningiomas developed in patients exposed to high-dose cyproterone acetate: an antiandrogen treatment |
| Q38979594 | Hypoxia inducible factor-1 is involved in growth factor, glucocorticoid and hypoxia mediated regulation of vascular endothelial growth factor-A in human meningiomas. |
| Q93133413 | Identification of KIF11 As a Novel Target in Meningioma |
| Q55000194 | Identification of key genes and pathways in meningioma by bioinformatics analysis. |
| Q48578191 | Immunocytochemical analysis of glucose transporter protein-1 (GLUT-1) in typical, brain invasive, atypical and anaplastic meningioma |
| Q34501813 | Immunohistochemical characterization of brain-invasive meningiomas |
| Q31012126 | Intracranial Meningiomas: A 30-Year Experience and Literature Review |
| Q38027778 | Intracranial clear cell meningioma in two children with blood relations: two case reports and literature review |
| Q36321407 | Intracranial meningioma with ophthalmoplegia in a rhesus macaque (Macaca mulatta). |
| Q36967473 | Intraoperative ultrasound assistance in resection of intracranial meningiomas |
| Q39182963 | Intraspinal meningioma with malignant transformation and distant metastasis |
| Q93018924 | Intraventricular meningiomas frequently harbor NF2 mutations but lack common genetic alterations in TRAF7, AKT1, SMO, KLF4, PIK3CA, and TERT |
| Q36953722 | Invasive benign meningioma: Clinical characteristics, surgical strategies and outcomes from a single neurosurgical institute |
| Q42241120 | Inversion-mediated gene fusions involving NAB2-STAT6 in an unusual malignant meningioma |
| Q82663858 | Isolation and characterization of tumor stem-like cells from human meningiomas |
| Q52764536 | KLF4 is a tumor suppressor in anaplastic meningioma stem-like cells and human meningiomas. |
| Q39369084 | Kallikrein-related peptidase 6 (KLK6)gene expression in intracranial tumors |
| Q39437747 | Key aspects in foramen magnum meningiomas: From old neuroanatomical conceptions to current far lateral neurosurgical intervention |
| Q88956093 | Letter to the editor: lung metastasis in WHO grade I meningioma |
| Q35644152 | Ligation-anchored PCR unveils immune repertoire of TCR-beta from whole blood |
| Q48682120 | Loss of p53 expression is accompanied by upregulation of beta-catenin in meningiomas: a concomitant reciprocal expression |
| Q24307712 | Loss of the Protein‐Tyrosine Phosphatase DEP‐1/PTPRJ Drives Meningioma Cell Motility |
| Q92322755 | Low Expression of Phosphatase and Tensin Homolog and High Expression of Ki-67 as Risk Factors of Prognosis in Cranial Meningiomas |
| Q91292000 | Low Transforming Growth Factor-β3 Expression Predicts Tumor Malignancy in Meningiomas |
| Q48714163 | Management of atypical cranial meningiomas, part 1: predictors of recurrence and the role of adjuvant radiation after gross total resection |
| Q84020259 | Management of meningeal neoplasms: meningiomas and hemangiopericytomas |
| Q21146660 | Mast cells in meningiomas and brain inflammation |
| Q44118008 | Meningioma |
| Q89104621 | Meningioma: The Tumor That Taught Us Neurosurgery |
| Q30368396 | Meningiomas and Proteomics: Focus on New Potential Biomarkers and Molecular Pathways. |
| Q97519828 | Meningiomas: An Overview of the Landscape of Copy Number Alterations in Samples from an Admixed Population |
| Q35392459 | Meningiomas: a comparative study of 68Ga-DOTATOC, 68Ga-DOTANOC and 68Ga-DOTATATE for molecular imaging in mice. |
| Q48626381 | Metastatic meningiomas: an unusual clinical and pathological diagnosis with highly variable outcome. |
| Q42291680 | MiR-34a-3p alters proliferation and apoptosis of meningioma cells in vitro and is directly targeting SMAD4, FRAT1 and BCL2 |
| Q26739662 | Molecular Genetics of Intracranial Meningiomas with Emphasis on Canonical Wnt Signalling |
| Q34631513 | Molecular Targets and Treatment of Meningioma |
| Q35145251 | Molecular biological determinations of meningioma progression and recurrence |
| Q92817234 | Molecular characteristics of meningiomas |
| Q48450830 | Multipronged quantitative proteomic analyses indicate modulation of various signal transduction pathways in human meningiomas. |
| Q64102900 | Neurofibromatosis type 2 gene mutation and progesterone receptor messenger RNA expression in the pathogenesis of sporadic orbitocranial meningioma |
| Q52661626 | Nursing review of spinal meningiomas. |
| Q46115389 | Overall survival benefit associated with adjuvant radiotherapy in WHO grade II meningioma |
| Q35943650 | Pathology and molecular genetics of meningioma: recent advances |
| Q33785024 | Pediatric meningioma: current approaches and future direction. |
| Q36590031 | Perfusion computed tomography of intracranial meningiomas: In vivo correlation of cerebral blood volume and vascular permeability |
| Q46444093 | Perspective on "the role of adjuvant radiotherapy after gross total resection of atypical meningiomas". |
| Q36740517 | Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma |
| Q41269979 | Prediction of Histological Grade and Completeness of Resection of Intracranial Meningiomas: Role of Peritumoural Brain Edema |
| Q36386374 | Predictors of recurrence in the management of chordoid meningioma |
| Q93158618 | Preoperative and Histological Predictors of Recurrence and Survival in Atypical Meningioma After Initial Gross Total Resection |
| Q30912220 | Preoperative radiologic classification of convexity meningioma to predict the survival and aggressive meningioma behavior |
| Q64098452 | Prevalence of hitherto unknown brain meningioma detected on Ga-DOTATATE positron-emission tomography/computed tomography in patients with metastatic neuroendocrine tumor and exploring potential of Lu-DOTATATE peptide receptor radionuclide therapy as |
| Q37699436 | Proposal for a new risk stratification classification for meningioma based on patient age, WHO tumor grade, size, localization, and karyotype. |
| Q33790175 | Proteomic data in meningiomas: post-proteomic analysis can reveal novel pathophysiological pathways |
| Q53675475 | Pseudo-continuous arterial spin labeling reflects vascular density and differentiates angiomatous meningiomas from non-angiomatous meningiomas. |
| Q35440783 | Quantitative proteomic analysis of meningiomas for the identification of surrogate protein markers |
| Q38782798 | RAS Promotes Proliferation and Resistances to Apoptosis in Meningioma |
| Q54109244 | Recent advances in managing/understanding meningioma. |
| Q37177786 | Relation of apparent diffusion coefficient with Ki-67 proliferation index in meningiomas. |
| Q47571067 | Rhabdoid Meningioma Arising Concurrent in Pulmonary and Intracranial with a Rare Malignant Clinical Progression: Case Report and Literature Review |
| Q38790141 | SMARCE1 mutation screening in classification of clear cell meningiomas |
| Q58914894 | SPECT and PET imaging of meningiomas |
| Q45388824 | Spinal meningioma in childhood: clinical features and treatment |
| Q47310904 | Stereotactic radiosurgery and radiotherapy for meningiomas: biomarker predictors of patient outcome and response to therapy |
| Q47127002 | Stereotactic radiosurgery as a salvage treatment option for atypical meningiomas previously submitted to surgical resection |
| Q64038759 | Successful treatment of anaplastic meningioma metastatic to cervical lymph nodes |
| Q38042846 | Surgical resection of pediatric skull base meningiomas |
| Q35894213 | Systematic Analysis of Outcomes for Surgical Resection and Radiotherapy in Patients with Papillary Meningioma |
| Q36849156 | TERT Promoter Mutations and Risk of Recurrence in Meningioma |
| Q38997320 | The Emerging Role of TRAF7 in Tumor Development |
| Q89753124 | The Expression of MIR17HG Protein as a Potential Therapeutic Target in Meningioma |
| Q53579500 | The Influence of Adjuvant Radiotherapy in Atypical and Anaplastic Meningiomas: A Series of 88 Patients in a Single Institution. |
| Q87844656 | The expression of the MSC-marker CD73 and of NF2/Merlin are correlated in meningiomas |
| Q35926564 | The histopathological spectrum of human meningiomas |
| Q34886859 | The mTOR signaling pathway as a treatment target for intracranial neoplasms |
| Q103826154 | The spatial phenotype of genotypically distinct meningiomas demonstrate potential implications of the embryology of the meninges |
| Q48627774 | Trabectedin has promising antineoplastic activity in high-grade meningioma |
| Q27853347 | Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO grade |
| Q39201329 | Transforming Growth Factor Beta Family in the Pathogenesis of Meningiomas |
| Q34233236 | Transglutaminase 2 expression is increased as a function of malignancy grade and negatively regulates cell growth in meningioma |
| Q40874821 | Treatment Response and Prognosis After Recurrence of Atypical Meningiomas |
| Q89868568 | Treatment of a Woman with Inoperable Meningioma Using Mifepristone for 26 Years |
| Q38422341 | Treatment-related secondary cancer in malignant meningiomas: a population-based study |
| Q91138602 | Ultrarapid Evaluation of Meningioma Malignancy by Intraoperative Flow Cytometry |
| Q39279815 | Uncommon Cranial Meningioma: Key Imaging Features on Conventional and Advanced Imaging |
| Q90145533 | [Intracranial Meningiomas: A Neurosurgical Disease? Possibilities and Limitations of Surgery] |
| Q38992048 | miR-200a-mediated suppression of non-muscle heavy chain IIb inhibits meningioma cell migration and tumor growth in vivo |
| Q43999077 | miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cells. |